BioNordic A/S: Financial statements 2023
CVR: 40831622
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioNordic A/S (CVR 40831622) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 95,559,123 and a net result of DKK 24,548,584 compared with DKK 5,156,853 the year before. That is an increase of 22.8% compared with the year before. Equity in the 2023 report amounted to DKK 48,871,298. The solvency ratio was 11.8%. The company had 83 employees in the financial year.
- Gross Profit
- DKK 95,559,123
- Profit/Loss
- DKK 24,548,584
- Equity
- DKK 48,871,298
- Total Assets
- DKK 413,922,077
- Employees
- 83
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 95.6M | 24.5M | 48.9M | 83 |
| 2022 | - | 77.8M | 5.2M | 24.8M | 98 |
| 2021 | - | 40.3M | 408K | 18.2M | 84 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 18, 2023, Lene Ploug Bülow has joined the board of directors of BioNordic A/S.
As of November 1, 2023, Jørn Martin Bank has left the board of directors of BioNordic A/S.
BioNordic A/S has published its annual report for 2022. Gross profit came to DKK 77,809,996, and the net result was DKK 5,156,853.
As of March 21, 2023, Nicolas Bødtker Nielsen has joined the board of directors of BioNordic A/S.
About BioNordic A/S
BioNordic A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Lene Ploug Bülow and Nicolas Bødtker Nielsen. The company's owners include Ole Bødtker Nielsen, Stefan Bødtker Michelsen and Nicolas Bødtker Nielsen. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 49,188,844 and a net result of DKK 131,702,212 compared with DKK -20,860,483 the year before. Equity in the 2025 report amounted to DKK 163,782,004.